EMD Serono Photos

EMD Serono
Basic research for new active ingredients: cultivating protein crystals for 3D structural analysis of active ingredients and target proteins.
Integrins are targeted by the angiogenesis inhibitor cilengitide. Dr. Simon L. Goodman from EMD’s preclinical cancer research team and Prof. Dr. M. Amin Arnaout from Mass General Hospital.

+ Add Photo

EMD Serono Reviews

42 Reviews
42 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
EMD Serono Chairman Karl-Ludwig Kley
Karl-Ludwig Kley
3 Ratings


    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Intern  in  Rockland, MA
    Former Employee - Intern in Rockland, MA

    I worked at EMD Serono as an intern for less than a year


    The best part about this place was the people tyat work there. Everyine is very friendly and willing to help


    The only downside gthat i can think of is that the billerica site is just too far from the city.

    Advice to ManagementAdvice

    Good company values and great leadership. The communication and support was great while i was there and i have only heard good ghings since.

    Positive Outlook
    No opinion of CEO

EMD Serono Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    EMD Co-op Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied through college or university. The process took 4+ weeks - interviewed at EMD Serono in May 2013.

    Interview Details

    applied through co-op advisor in college and got call for 2 of the positions

    No Offer
    Negative Experience
    Average Interview

EMD Serono Awards & Accolades

Something missing? Add an award
Training Top 125, Training, 2012
Training Top 125, Training, 2009
Show More

Additional Info

Unlock Profile
Website www.come2emd.com
Headquarters Rockland, MA
Size 1000 to 5000 Employees
Founded 1982
Type Subsidiary or Business Segment
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year
Competitors Amgen, Novartis

As part of Merck KGaA, Darmstadt Germany, EMD Serono discovers, develops, manufactures and commercializes innovative biopharmaceuticals and therapies for high unmet medical needs. The focus lies in specialized therapeutic areas such as oncology, multiple sclerosis and infertility. Through their targeted effect, these medicines help patients live longer and better lives.

Within the United States, EMD Serono has more than 1,000 employees working in fully integrated commercial, clinical, and research operations near Boston, and headquarters in Rockland, Massachusetts....

Worked for EMD Serono? Contribute to the Community!